siRNA therapy lowers triglycerides in people with uncommon health condition

.ANALYSIS EMPHASIZE.19 September 2024.

Plozasiran reduced triglyceride levels by 80% and lowered the threat of pancreatitis in individuals along with constant chylomicronemia, along with or even without a hereditary prognosis.